Irinotecan is one specific topoisomerase I (TOP1) inhibitor, but down-regulation of TOP1 has been found in some colon cancer cases, leading to reduced therapeutic effect of irinotecan. The gene discussed is TOP1; the disease is malignant colon neoplasm.